Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Barbieri

Showing results (241-250 of 305) with videos related to

Pageof 31
Sort By:
Veterinary Parasitology|October 4, 2017
Terminalia catappa: Chemical composition, in vitro and in vivo effects on Haemonchus contortusL M Katiki, A C P Gomes, A M E Barbieri, et al.
The Prostate|June 10, 2023
Prostate cancer genetic alterations in Hispanic menCamilo Arenas-Gallo, Stephen Rhodes, Jorge A Garcia, et al.
Nature Reviews. Urology|August 9, 2022
Race and prostate cancer: genomic landscapeCamilo Arenas-Gallo, Jude Owiredu, Ilon Weinstein, et al.
European Urology|April 8, 2017
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase InhibitionAditya Dutta, Sukanya Panja, Renu K Virk, et al.
Urologic Oncology|March 21, 2020
Prognostic value of the SPOP mutant genomic subclass in prostate cancerJonathan Shoag, Deli Liu, Xiaoyue Ma, et al.
Leukemia & Lymphoma|June 1, 1996
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphomaP L Zinzani, M Zompatori, M Bendandi, et al.
ESMO Open|February 14, 2021
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID eraA Toss, C Isca, M Venturelli, et al.
Nature Communications|November 19, 2021
G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancerChandrani Mukhopadhyay, Chenyi Yang, Limei Xu, et al.
The Journal of Clinical Investigation|May 17, 2021
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancerDeli Liu, Michael A Augello, Ivana Grbesa, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 5, 2012
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome ConsortiumRaquel Esgueva, Kyung Park, Robert Kim, et al.
Pageof 31

Showing results (241-250 of 305) with videos related to

Sort By:
Pageof 31
Veterinary Parasitology|October 4, 2017
Terminalia catappa: Chemical composition, in vitro and in vivo effects on Haemonchus contortusL M Katiki, A C P Gomes, A M E Barbieri, et al.
The Prostate|June 10, 2023
Prostate cancer genetic alterations in Hispanic menCamilo Arenas-Gallo, Stephen Rhodes, Jorge A Garcia, et al.
Nature Reviews. Urology|August 9, 2022
Race and prostate cancer: genomic landscapeCamilo Arenas-Gallo, Jude Owiredu, Ilon Weinstein, et al.
European Urology|April 8, 2017
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase InhibitionAditya Dutta, Sukanya Panja, Renu K Virk, et al.
Urologic Oncology|March 21, 2020
Prognostic value of the SPOP mutant genomic subclass in prostate cancerJonathan Shoag, Deli Liu, Xiaoyue Ma, et al.
Leukemia & Lymphoma|June 1, 1996
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphomaP L Zinzani, M Zompatori, M Bendandi, et al.
ESMO Open|February 14, 2021
Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID eraA Toss, C Isca, M Venturelli, et al.
Nature Communications|November 19, 2021
G3BP1 inhibits Cul3<sup>SPOP</sup> to amplify AR signaling and promote prostate cancerChandrani Mukhopadhyay, Chenyi Yang, Limei Xu, et al.
The Journal of Clinical Investigation|May 17, 2021
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancerDeli Liu, Michael A Augello, Ivana Grbesa, et al.
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|May 5, 2012
Next-generation prostate cancer biobanking: toward a processing protocol amenable for the International Cancer Genome ConsortiumRaquel Esgueva, Kyung Park, Robert Kim, et al.
Pageof 31